About this trial
Most chronic pain patients have mood disorders. The mood disorders may improve with better analgesia produced by Ketamine injections. A prospective study of patients undergoing interventional pain therapy using Ketamine injections. Pre-injection and post-injection patient data is collected. Pain is measured using numeric pain rating scale, and change in pain score by 2-points is considered significant. Sleep is measured using Likert sleep scale, and change in sleep score by 2-points is considered significant. Anxiety is measured using general anxiety disorder (GAD-7) scale, and change in anxiety score by 4-points is considered significant. Depression is measured using patient health questionnaire (PHQ-9), and change in depression score by 5-points is considered significant.
Eligibility criteria
Qualifiers
adult chronic pain patients
associated mood disorder
good treatment compliance
associated chronic insomnia
Disqualifiers
severe cognitive disorder
inability to provide consent
major neuropsychiatric disorder
cannabis use
Trial design
Treatments tested in this trial
- Not listed